These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32422328)

  • 1. Poly (ADP-Ribose) polymerase-1 (PARP-1) overactivity plays a pathogenic role in bile acids-induced nephrotoxicity in cholestatic rats.
    Siavashpour A; Khalvati B; Azarpira N; Mohammadi H; Niknahad H; Heidari R
    Toxicol Lett; 2020 May; 330():144-158. PubMed ID: 32422328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity.
    Ahmadi A; Niknahad H; Li H; Mobasheri A; Manthari RK; Azarpira N; Mousavi K; Khalvati B; Zhao Y; Sun J; Zong Y; Ommati MM; Heidari R
    Toxicol Lett; 2021 Oct; 349():12-29. PubMed ID: 34089816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silymarin mitigates bile duct obstruction-induced cholemic nephropathy.
    Ommati MM; Farshad O; Azarpira N; Ghazanfari E; Niknahad H; Heidari R
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1301-1314. PubMed ID: 33538845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of cirrhosis-related renal injury by N-acetyl cysteine.
    Abdoli N; Sadeghian I; Mousavi K; Azarpira N; Ommati MM; Heidari R
    Curr Res Pharmacol Drug Discov; 2020 Apr; 1():30-38. PubMed ID: 34909640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis-inducing factor plays a role in the pathogenesis of hepatic and renal injury during cholestasis.
    Ghanbarinejad V; Jamshidzadeh A; Khalvati B; Farshad O; Li H; Shi X; Chen Y; Ommati MM; Heidari R
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1191-1203. PubMed ID: 33527194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction as a mechanism involved in the pathogenesis of cirrhosis-associated cholemic nephropathy.
    Heidari R; Mandegani L; Ghanbarinejad V; Siavashpour A; Ommati MM; Azarpira N; Najibi A; Niknahad H
    Biomed Pharmacother; 2019 Jan; 109():271-280. PubMed ID: 30396085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline mitigates cholestasis-related cholemic nephropathy.
    Ommati MM; Hojatnezhad S; Abdoli N; Manthari RK; Jia Z; Najibi A; Akbarizadeh AR; Sadeghian I; Farshad O; Azarpira N; Niknahad H; Heidari R
    Clin Exp Hepatol; 2021 Dec; 7(4):377-389. PubMed ID: 35402721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Mar; 99():1022-1032. PubMed ID: 29307496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary inflammation, oxidative stress, and fibrosis in a mouse model of cholestasis: the potential protective properties of the dipeptide carnosine.
    Ommati MM; Sabouri S; Niknahad H; Arjmand A; Alidaee S; Mazloomi S; Najibi A; Rezaei H; Ghiasvand A; Ahmadi P; Nikoozadeh A; Khodaei F; Abdoli N; Azarpira N; Heidari R
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1129-1142. PubMed ID: 36651945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine mitigates bile duct obstruction-associated cholemic nephropathy: effect on oxidative stress and mitochondrial parameters.
    Abdoli N; Sadeghian I; Azarpira N; Ommati MM; Heidari R
    Clin Exp Hepatol; 2021 Mar; 7(1):30-40. PubMed ID: 34027113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestasis-Associated Pulmonary Inflammation, Oxidative Stress, and Tissue Fibrosis: The Protective Role of the Biogenic Amine Agmatine.
    Ommati MM; Niknahad H; Najibi A; Arjmand A; Alidaee S; Mazloomi S; Ahmadi P; Ghiasvand A; Javadi M; Yazdani J; Sabouri S; Rezaei H; Azarpira N; Heidari R
    Pharmacology; 2023; 108(4):379-393. PubMed ID: 37253339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
    Iruzubieta P; Goikoetxea-Usandizaga N; Barbier-Torres L; Serrano-Maciá M; Fernández-Ramos D; Fernández-Tussy P; Gutiérrez-de-Juan V; Lachiondo-Ortega S; Simon J; Bravo M; Lopitz-Otsoa F; Robles M; Ferre-Aracil C; Varela-Rey M; Elguezabal N; Calleja JL; Lu SC; Milkiewicz M; Milkiewicz P; Anguita J; Monte MJ; Marin JJG; López-Hoyos M; Delgado TC; Rincón M; Crespo J; Martínez-Chantar ML
    JHEP Rep; 2021 Jun; 3(3):100276. PubMed ID: 33997750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.
    Ghallab A; González D; Strängberg E; Hofmann U; Myllys M; Hassan R; Hobloss Z; Brackhagen L; Begher-Tibbe B; Duda JC; Drenda C; Kappenberg F; Reinders J; Friebel A; Vucur M; Turajski M; Seddek AL; Abbas T; Abdelmageed N; Morad SAF; Morad W; Hamdy A; Albrecht W; Kittana N; Assali M; Vartak N; van Thriel C; Sous A; Nell P; Villar-Fernandez M; Cadenas C; Genc E; Marchan R; Luedde T; Åkerblad P; Mattsson J; Marschall HU; Hoehme S; Stirnimann G; Schwab M; Boor P; Amann K; Schmitz J; Bräsen JH; Rahnenführer J; Edlund K; Karpen SJ; Simbrunner B; Reiberger T; Mandorfer M; Trauner M; Dawson PA; Lindström E; Hengstler JG
    J Hepatol; 2024 Feb; 80(2):268-281. PubMed ID: 37939855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetyl cysteine treatment mitigates biomarkers of oxidative stress in different tissues of bile duct ligated rats.
    Ommati MM; Amjadinia A; Mousavi K; Azarpira N; Jamshidzadeh A; Heidari R
    Stress; 2021 Mar; 24(2):213-228. PubMed ID: 32510264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestasis-associated reproductive toxicity in male and female rats: The fundamental role of mitochondrial impairment and oxidative stress.
    Ommati MM; Farshad O; Niknahad H; Arabnezhad MR; Azarpira N; Mohammadi HR; Haghnegahdar M; Mousavi K; Akrami S; Jamshidzadeh A; Heidari R
    Toxicol Lett; 2019 Nov; 316():60-72. PubMed ID: 31520699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation.
    Ommati MM; Mobasheri A; Ma Y; Xu D; Tang Z; Manthari RK; Abdoli N; Azarpira N; Lu Y; Sadeghian I; Mousavifaraz A; Nadgaran A; Nikoozadeh A; Mazloomi S; Mehrabani PS; Rezaei M; Xin H; Mingyu Y; Niknahad H; Heidari R
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Dec; 395(12):1557-1572. PubMed ID: 36097067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation of nuclear factor-E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling blunts cholestasis-induced liver and kidney injury.
    Mousavi K; Niknahad H; Li H; Jia Z; Manthari RK; Zhao Y; Shi X; Chen Y; Ahmadi A; Azarpira N; Khalvati B; Ommati MM; Heidari R
    Toxicol Res (Camb); 2021 Aug; 10(4):911-927. PubMed ID: 34484683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and mitochondrial taurine depletion in bile duct ligated rats: a justification for taurine supplementation in cholestasis/cirrhosis.
    Najibi A; Rezaei H; Manthari RK; Niknahad H; Jamshidzadeh A; Farshad O; Yan F; Ma Y; Xu D; Tang Z; Ommati MM; Heidari R
    Clin Exp Hepatol; 2022 Sep; 8(3):195-210. PubMed ID: 36685263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empagliflozin Exhibits Hepatoprotective Effects Against Bile Duct Ligation-induced Liver Injury in Rats: A Combined Molecular Docking Approach to In Vivo Studies.
    Shakerinasab N; Azizi M; Mansourian M; Sadeghi H; Salaminia S; Abbasi R; Shahaboddin ME; Doustimotlagh AH
    Curr Pharm Des; 2022; 28(40):3313-3323. PubMed ID: 36305136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.